Profile data is unavailable for this security.
About the company
Black Bird Biotech, Inc. is a manufacturer and distributor for MiteXstream, an environmental protection agency (EPA)-certified plant-based biopesticide effective in the eradication of mites and other similar pests, including spider mites, that destroy crops, particularly cannabis, hops, coffee and house plants, as well as molds and mildew. The Company also manufactures and sells, under its Grizzly Creek Naturals brand name, cannabidiol (CBD) products, including CBD Oils, gummies and pet treats, as well as CBD-infused personal care products. Big Sky American Dist., LLC (Big Sky American) distributes its Grizzly Creek Naturals products, as well as an array of other consumer retail products, in Western Montana. The Company's subsidiaries include Black Bird Potentials Inc. (BB Potentials), Big Sky American Dist., LLC (Big Sky American) and Black Bird Hemp Manager, LLC.
- Revenue in USD (TTM)36.33k
- Net income in USD-836.14k
- Incorporated2006
- Employees4.00
- LocationBlack Bird Biotech Inc11961 HILLTOP ROAD, SUITE 22ARGYLE 76226United StatesUSA
- Phone+1 (626) 581-3335
- Fax+1 (626) 581-4121
- Websitehttps://blackbirdbiotech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rapid Therapeutic Science Laborators Inc | 0.00 | 59.55k | 25.09k | 3.00 | 0.2044 | -- | 0.2395 | -- | 0.0059 | 0.0059 | 0.00 | -0.3101 | 0.00 | 0.00 | -- | 0.00 | 2.64 | -- | -- | -- | -- | -- | -- | -- | 0.0323 | -0.9303 | 4.87 | -- | -100.00 | -- | 37.42 | -- | -- | -- |
Black Bird Biotech Inc | 36.33k | -836.14k | 98.40k | 4.00 | -- | -- | -- | 2.71 | -0.0018 | -0.0018 | 0.00005 | -0.0005 | 0.2718 | 0.3178 | 13.31 | 9,082.50 | -625.64 | -433.36 | -- | -- | 27.55 | -- | -2,301.51 | -1,800.06 | 0.0154 | -0.6032 | -- | -- | -20.96 | -- | 8.42 | -- | -- | -- |